175 related articles for article (PubMed ID: 35242665)
1. Novel mutations of the calcium-sensing receptor impede differential diagnosis of primary hyperparathyroidism and familial hypocalciuric hypercalcemia.
Bhangu JS; Baumgartner-Parzer S; Hargitai L; Mazal P; Scheuba C; Riss P
Gland Surg; 2022 Jan; 11(1):12-22. PubMed ID: 35242665
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone-dependent familial hypercalcemia with low measured PTH levels and a presumptive novel pathogenic mutation in CaSR.
Mahajan A; Buse J; Kline G
Osteoporos Int; 2020 Jan; 31(1):203-207. PubMed ID: 31641801
[TBL] [Abstract][Full Text] [Related]
3. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.
Stratta P; Merlotti G; Musetti C; Quaglia M; Pagani A; Izzo C; Radin E; Airoldi A; Baorda F; Palladino T; Leone MP; Guarnieri V
Nephrol Dial Transplant; 2014 Oct; 29(10):1902-9. PubMed ID: 25104082
[TBL] [Abstract][Full Text] [Related]
4. Concomitant familial hypocalciuric hypercalcemia and single parathyroid adenoma: a case report.
Marstrand SD; Tofteng CL; Jarløv A; Borgwardt L; Schwarz P
J Med Case Rep; 2021 Sep; 15(1):471. PubMed ID: 34556169
[TBL] [Abstract][Full Text] [Related]
5. Familial hypocalciuric hypercalcemia in an index male: grey zones of the differential diagnosis from primary hyperparathyroidism in a 13-year clinical follow up.
Zajíčková K; Dvořáková M; Moravcová J; Včelák J; Goltzman D
Physiol Res; 2020 Sep; 69(Suppl 2):S321-S328. PubMed ID: 33094630
[TBL] [Abstract][Full Text] [Related]
6. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
[TBL] [Abstract][Full Text] [Related]
7. Think twice: a rare calcium sensing receptor mutation and a new diagnosis of familial hypocalciuric hypercalcaemia.
Tellam JJ; Abdulrasool G; Ciin LCH
Endocrinol Diabetes Metab Case Rep; 2020 Jun; 2020():. PubMed ID: 32698162
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of calcium excretion and calcium/creatinine clearance ratio in the differential diagnosis of familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
Bhangu JS; Selberherr A; Brammen L; Scheuba C; Riss P
Head Neck; 2019 May; 41(5):1372-1378. PubMed ID: 30554440
[TBL] [Abstract][Full Text] [Related]
9. Genetics of hereditary forms of primary hyperparathyroidism.
English KA; Lines KE; Thakker RV
Hormones (Athens); 2024 Mar; 23(1):3-14. PubMed ID: 38038882
[TBL] [Abstract][Full Text] [Related]
10. Familial Hypocalciuric Hypercalcemia as an Atypical Form of Primary Hyperparathyroidism.
Marx SJ
J Bone Miner Res; 2018 Jan; 33(1):27-31. PubMed ID: 29115694
[TBL] [Abstract][Full Text] [Related]
11. Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods.
Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Brixen K; Mosekilde L
Clin Endocrinol (Oxf); 2008 Nov; 69(5):713-20. PubMed ID: 18410554
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous Mutation (Q459R) in the Calcium-Sensing Receptor Gene Causes Familial Hypocalciuric Hypercalcemia 1 (FHH1).
Boisen IM; Mos I; Lerche-Black EM; Juul A; Bräuner-Osborne H; Blomberg Jensen M
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32160303
[TBL] [Abstract][Full Text] [Related]
13. Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism.
Shinall MC; Dahir KM; Broome JT
Endocr Pract; 2013; 19(4):697-702. PubMed ID: 23425644
[TBL] [Abstract][Full Text] [Related]
14. The pathophysiology of primary hyperparathyroidism.
Brown EM
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N24-9. PubMed ID: 12412774
[TBL] [Abstract][Full Text] [Related]
15. A novel mouse model for familial hypocalciuric hypercalcemia (FHH1) reveals PTH-dependent and independent CaSR defects.
Küng CJ; Daryadel A; Fuente R; Haykir B; de Angelis MH; Hernando N; Rubio-Aliaga I; Wagner CA
Pflugers Arch; 2024 May; 476(5):833-845. PubMed ID: 38386045
[TBL] [Abstract][Full Text] [Related]
16. Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences.
Vargas-Poussou R; Mansour-Hendili L; Baron S; Bertocchio JP; Travers C; Simian C; Treard C; Baudouin V; Beltran S; Broux F; Camard O; Cloarec S; Cormier C; Debussche X; Dubosclard E; Eid C; Haymann JP; Kiando SR; Kuhn JM; Lefort G; Linglart A; Lucas-Pouliquen B; Macher MA; Maruani G; Ouzounian S; Polak M; Requeda E; Robier D; Silve C; Souberbielle JC; Tack I; Vezzosi D; Jeunemaitre X; Houillier P
J Clin Endocrinol Metab; 2016 May; 101(5):2185-95. PubMed ID: 26963950
[TBL] [Abstract][Full Text] [Related]
17. Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism.
Frank-Raue K; Leidig-Bruckner G; Haag C; Schulze E; Lorenz A; Schmitz-Winnenthal H; Raue F
Clin Endocrinol (Oxf); 2011 Jul; 75(1):50-5. PubMed ID: 21521328
[TBL] [Abstract][Full Text] [Related]
18. Persistent hypercalcemia with similar familial Hypocalciuric hypercalcemia features: a case report and literature review.
Zahedi M; Hizomi Arani R; Rafati M; Amouzegar A; Hadaegh F
BMC Endocr Disord; 2021 Nov; 21(1):220. PubMed ID: 34736428
[TBL] [Abstract][Full Text] [Related]
19. Codon Arg15 mutations of the AP2S1 gene: common occurrence in familial hypocalciuric hypercalcemia cases negative for calcium-sensing receptor (CASR) mutations.
Hendy GN; Canaff L; Newfield RS; Tripto-Shkolnik L; Wong BY; Lee BS; Cole DE
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1311-5. PubMed ID: 24731014
[TBL] [Abstract][Full Text] [Related]
20. Expanding the spectrum of genetic variants in the calcium-sensing receptor (CASR) gene in hypercalcemic individuals.
Nissen PH; Rejnmark L
Clin Endocrinol (Oxf); 2019 Nov; 91(5):683-690. PubMed ID: 31433865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
